نتائج البحث - Pedro Mendes‐Bastos

  • يعرض 1 - 15 نتائج من 15
تنقيح النتائج
  1. 1
    From PsO to PsA: the role of TRM and Tregs in psoriatic disease, a systematic review of the literature

    From PsO to PsA: the role of TRM and Tregs in psoriatic disease, a systematic review of the literature حسب Bárbara Lobão, Diana Lourenço, Ana Giga, Pedro Mendes‐Bastos

    منشور في 2024
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Utilidade da Ecografia Cutânea na Celulite Dissecante: A Propósito de 2 Casos Clínicos

    Utilidade da Ecografia Cutânea na Celulite Dissecante: A Propósito de 2 Casos Clínicos حسب Aline Aline, Pedro Mendes‐Bastos, Diana Miguel, Rui Oliveira Soares

    منشور في 2021
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Update on Atopic Dermatitis

    Update on Atopic Dermatitis حسب Tiago Torres, Eduarda Osório Ferreira, Margarida Gonçalo, Pedro Mendes‐Bastos, Manuela Selores, Paulo Filipe

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    The use of ultrasound and magnetic resonance imaging in the management of hidradenitis suppurativa: a narrative review

    The use of ultrasound and magnetic resonance imaging in the management of hidradenitis suppurativa: a narrative review حسب Pedro Mendes‐Bastos, Antonio Martorell, Vincenzo Bettoli, António P Matos, Elisa Muscianisi, Ximena Wortsman

    منشور في 2023
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Bruton's tyrosine kinase inhibition—An emerging therapeutic strategy in immune‐mediated dermatological conditions

    Bruton's tyrosine kinase inhibition—An emerging therapeutic strategy in immune‐mediated dermatological conditions حسب Pedro Mendes‐Bastos, Ana Brasileiro, Pavel Kolkhir, Stefan Frischbutter, Jörg Scheffel, Sherezade Moñino‐Romero, Marcus Maurer

    منشور في 2022
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Interleukin-4 and Atopic Dermatitis: Why Does it Matter? A Narrative Review

    Interleukin-4 and Atopic Dermatitis: Why Does it Matter? A Narrative Review حسب Tiago Torres, Pedro Mendes‐Bastos, Maria João Cruz, Bruno Kosa Lino Duarte, Paulo Filipe, Maria João Paiva Lopes, Margarida Gonçalo

    منشور في 2025
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    The APOLO Study: A Cross-Sectional Analysis of Disease Characteristics and Patient Burden in Moderate-to-Severe Atopic Dermatitis in Portugal

    The APOLO Study: A Cross-Sectional Analysis of Disease Characteristics and Patient Burden in Moderate-to-Severe Atopic Dermatitis in Portugal حسب Bruno Kosa Lino Duarte, Pedro Mendes‐Bastos, Joana Antunes, Filomena Azevedo, Margarida Gonçalo, Martinha Henrique, V. Marques, Isabel Freitas, Tiago Torres

    منشور في 2025
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Characterization of acne associated with upadacitinib treatment in patients with moderate-to-severe atopic dermatitis: A post hoc integrated analysis of 3 phase 3 randomized, double-blind, placebo-controlled trials

    Characterization of acne associated with upadacitinib treatment in patients with moderate-to-severe atopic dermatitis: A post hoc integrated analysis of 3 phase 3 randomized, doubl... حسب Pedro Mendes‐Bastos, Barry Ladizinski, Emma Guttman‐Yassky, Ping Jiang, John Liu, Vimal H. Prajapati, Eric L. Simpson, Namita Vigna, Henrique D. Teixeira, S. Barbarot

    منشور في 2022
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    Secukinumab in patients with moderate-to-severe hidradenitis suppurativa based on prior biologic exposure: an efficacy and safety analysis from the SUNSHINE and SUNRISE phase III trials

    Secukinumab in patients with moderate-to-severe hidradenitis suppurativa based on prior biologic exposure: an efficacy and safety analysis from the SUNSHINE and SUNRISE phase III t... حسب Christos C. Zouboulis, Thierry Passeron, David M. Pariser, Magdalena B. Wozniak, Xianjun Li, Lorenz Uhlmann, Iryna Lobach, Angela Llobet Martinez, Shoba Ravichandran, Ivette Alarcón, Annamaria Offidani, Maryam Shayesteh Alam, Pedro Mendes‐Bastos

    منشور في 2024
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    Efficacy and Safety of Upadacitinib vs Dupilumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: Week 16 results of an Open-label, Randomized, Efficacy Assessor-Blinded Head-to-Head Phase 3b/4 Study (Level Up)

    Efficacy and Safety of Upadacitinib vs Dupilumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: Week 16 results of an Open-label, Randomized, Efficacy Assesso... حسب Jonathan I. Silverberg, Christopher G. Bunick, Hwanhee Hong, Pedro Mendes‐Bastos, Linda Stein Gold, Antonio Costanzo, Nadia Ibrahim, Cristina Sancho, Xiaoqiang Wu, Yu Jin Han, Gweneth Levy, Kathy Altman, Brian Calimlim, Kilian Eyerich

    منشور في 2024
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    <scp>Real‐world</scp> clinical, psychosocial and economic burden of atopic dermatitis: Results from a multicountry study

    <scp>Real‐world</scp> clinical, psychosocial and economic burden of atopic dermatitis: Results from a multicountry study حسب Kilian Eyerich, Melinda Gooderham, Juan Francisco Silvestre, Stephen Shumack, Pedro Mendes‐Bastos, Valéria Aoki, Michela Ortoncelli, Jonathan I. Silverberg, Henrique D. Teixeira, Shirley H. Chen, Brian Calimlim, Shunya Takemoto, Cristina Sancho, Björn Fritz, Alan D. Irvine

    منشور في 2023
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    Secukinumab demonstrates improvements in absolute and relative psoriasis area severity indices in moderate-to-severe plaque psoriasis: results from a European, multicentric, retrospective, real-world study

    Secukinumab demonstrates improvements in absolute and relative psoriasis area severity indices in moderate-to-severe plaque psoriasis: results from a European, multicentric, retros... حسب Andrea Chiricozzi, Anna Balato, Curdin Conrad, Andrea Conti, Paolo Dapavo, Paulo Ferreira, Francesca Maria Gaiani, Luíz Leite, Piergiorgio Malagoli, Pedro Mendes‐Bastos, Matteo Megna, Francesco Messina, Alessia Nidegger, Giulia Odorici, Salvatore Panduri, Stefano Piaserico, Leonardo Piscitelli, Francesca Prignano, Simone Ribero, Joana Valério, Tiago Torres

    منشور في 2019
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    Efficacy and Safety of Upadacitinib Treatment in Adolescents With Moderate-to-Severe Atopic Dermatitis

    Efficacy and Safety of Upadacitinib Treatment in Adolescents With Moderate-to-Severe Atopic Dermatitis حسب Amy S. Paller, Barry Ladizinski, Pedro Mendes‐Bastos, Elaine C. Siegfried, Weily Soong, Vimal H. Prajapati, Peter Lio, Jacob P. Thyssen, Eric L. Simpson, Andrew M. Platt, Eliza M. Raymundo, Jianzhong Liu, Brian Calimlim, Xiaohong Huang, Yihua Gu, Xiaofei Hu, Yang Yang, John Su, Min Zheng, Kiwako Yamamoto‐Hanada, Henrique D. Teixeira, Alan D. Irvine

    منشور في 2023
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  14. 14
    Epidemiology of Psoriasis in Portugal: A Population-Based Study

    Epidemiology of Psoriasis in Portugal: A Population-Based Study حسب Tiago Torres, Paulo Filipe, Francisco Menezes Brandão, Américo Figueiredo, A. Pinto Soares, A. Sousa Basto, Clarisse Rebelo, Osvaldo Correia, Paulo Ferreira, Ana Brasileiro, Pedro Mendes‐Bastos, Maria João Paiva Lopes, Gabriela Marques Pinto, Mílton Severo, Denisa Mendonça, Pedro Oliveira, Manuela Selores, António Massa, Marta Pereira, Rui Tavares Bello, On behalf of the Portuguese Psoriasis Group of the Portuguese Society of Dermatology and Venereology

    منشور في 2023
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  15. 15
    Drug Survival of IL-12/23, IL-17 and IL-23 Inhibitors for Psoriasis Treatment: A Retrospective Multi-Country, Multicentric Cohort Study

    Drug Survival of IL-12/23, IL-17 and IL-23 Inhibitors for Psoriasis Treatment: A Retrospective Multi-Country, Multicentric Cohort Study حسب Tiago Torres, L. Puig, Ronald Vender, Charles Lynde, Stefano Piaserico, J.M. Carrascosa, Paolo Gisondi, E. Daudén, Curdin Conrad, Pedro Mendes‐Bastos, Paulo Ferreira, Luíz Leite, Justin D. Lu, Joana Valério, Manfredo Bruni, Francesco Messina, Alessia Nidegger, Mar Llamas‐Velasco, E. del Alcázar, Asfandyar Mufti, Kyra White, Giacomo Caldarola, Laetitia Teixeira, Paolo Romanelli, K. Desai, Spyridon Gkalpakiotis, Marco Romanelli, Jensen Yeung, Miguel Nogueira, Andrea Chiricozzi

    منشور في 2021
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: